Optical based delivery of exogenous molecules to cells
View Patent ↗A method of delivering exogenous molecules, comprising: providing a plurality of cells having a cell membrane; adding a plurality of exogenous molecules to the cells; exposing the cells to a defocused infrared (IR) light to permeabilize the cell membrane of the cells; and delivering the exogenous molecules to the cells through the permeablized cell membrane, wherein an intensity of the IR light at the optical focus is at least greater than or equal to an order of 10 4 W/cm 2 .
1. A method of delivering exogenous molecules, comprising:
providing a plurality of cells having a cell membrane;
adding a plurality of exogenous molecules to the cells;
exposing the cells to an infra-red (IR) light to permeabilize the cell membrane for delivering the exogenous molecules to the cells through the permeablized cell membrane,
wherein an average power density of the IR light at the optical focus is greater than or equal to an order of 10 4 W/cm 2 , and a peak power density is greater than or equal to an order of 10 8 W/cm 2 , and
wherein an area of irradiation of the IR light is in a range from about 50 to 200 μm 2 .
2. The method of claim 1 , wherein an average power of the IR light is in a range from about 100 to 200 mW.
3. The method of claim 1 , wherein the IR light is a laser.
4. The method of claim 3 , wherein the laser is a pulse laser with a wavelength greater than 700 nm, a pulse width greater than 1 psec, and a repetition rate greater than 1 MHz.
5. The method of claim 1 , wherein the cells are exposed for about 1 second to 10 minutes.
6. The method of claim 1 is a transfection.
7. The method of claim 6 , wherein the transfection is a high throughput transfection.
8. The method of claim 1 , wherein the cells are selected from a group consisting of bacterial cells, yeast cells, plant cells, and animal cells.
9. The method of claim 1 , wherein the cells are in a static or a moving condition.
10. The method of claim 1 , wherein the exogenous molecules are selected from the group consisting of small molecules, genetic materials, proteins, peptides organelle, physiologically active material, and targeting agents.
11. The method of claim 10 , wherein the genetic material comprises deoxyribonucleic acids (DNA), ribonucleic acids (RNA), siRNAs, micro RNA, nucleic acid analogues, oligonucleotides, plasmids, and chromosomes.
12. The method of claim 11 , wherein the genetic material is DNA.
13. The method of claim 12 , wherein the DNA has a recombination site.
14. The method of claim 12 , wherein the DNA comprises a target sequence that codes for an expression product.
15. The method of claim 14 , wherein the expression product is capable of eliciting an immune response.
16. The method of claim 11 , wherein the genetic material comprises siRNA.
17. The method of claim 1 , wherein the exogenous molecules are coupled to one or more agents selected from a group consisting of a bead, an affinity tag, a signal peptide, a nanoparticle, a vesicle, a lipid and combinations thereof.
18. The method of claim 1 further comprising, adding one or more nanoparticles.
19. The method of claim 1 , wherein exposing the cells to the IR light is followed by use of magnetic field to co-localize the cells and exogenous molecules at the optical focus.
20. The method of claim 1 , wherein exposing the cells to the IR light is associated with treating the cells with one or more chemicals to increase permeability of the cells.
21. The method of claim 1 , further comprising exposing some of the cells to the IR light by keeping the cells at the optical focus for ablating the cells.